Related Articles
Cx43 reverses the resistance of A549 lung adenocarcinoma cells to cisplatin by inhibiting EMT
The CK2 inhibitor CX4945 reverses cisplatin resistance in the A549/DDP human lung adenocarcinoma cell line
miR-133b reverses cisplatin resistance by targeting GSTP1 in cisplatin-resistant lung cancer cells
Treatment with 20(S)-ginsenoside Rg3 reverses multidrug resistance in A549/DDP xenograft tumors
Inhibitor of DNA binding 3 reverses cisplatin resistance in human lung adenocarcinoma cells by regulating the PI3K/Akt pathway